Please use this identifier to cite or link to this item:
Title: Single-dose and steady-state pharmacokinetics of doxazosin given in combination with chlorothiazide to hypertensive subjects.
Austin Authors: Conway, Elizabeth L;McNeil, John J;Meng, L;Drummer, Olaf H;Howes, L G;Raymond, K;Louis, William J 
Affiliation: University of Melbourne, Clinical Pharmacology and Therapeutics Units, Austin Hospital, Heidelberg, Victoria, Australia
Issue Date: 1-Jun-1989
Publication information: Clinical Pharmacokinetics; 16(6): 387-91
Abstract: The pharmacokinetics of doxazosin were determined in hypertensive subjects after a single dose of 1 mg, and at steady-state while receiving doses of 1, 2, 4 and 8 mg of the drug daily. Chlorothiazide 500 mg once daily was administered as additional therapy throughout the study. After a single dose doxazosin was rapidly absorbed, with peak plasma drug concentrations (Cmax) occurring after 2.1 +/- 0.4 hours. The elimination half-life in plasma was 10.7 +/- 1.2 hours. These parameters remained essentially unchanged during maintenance administration of doxazosin at each of the dose levels. Calculations of Cmax and area under the concentration-time curve (AUC0----infinity) indicated that the pharmacokinetic disposition of the drug remained linear over the dose range 1 to 8 mg.
Gov't Doc #: 2525447
DOI: 10.2165/00003088-198916060-00004
Journal: Clinical pharmacokinetics
Type: Journal Article
Subjects: Adult
Antihypertensive Agents.adverse effects.pharmacokinetics.therapeutic use
Blood Pressure.drug effects
Chlorothiazide.adverse effects.pharmacokinetics.therapeutic use
Hypertension.drug therapy.metabolism.physiopathology
Middle Aged
Prazosin.adverse effects.analogs & derivatives.pharmacokinetics.therapeutic use
Appears in Collections:Journal articles

Files in This Item:
File SizeFormat 
2525447.pdf44.3 kBAdobe PDFView/Open
Show full item record

Page view(s)

checked on Dec 5, 2023


checked on Dec 5, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.